NIAGEN BIOSCIENCE, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value

NIAGEN BIOSCIENCE, INC. (NAGE) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value of $15.54 thousand as of 2012-12-29, per its 10-K filed 2013-03-29.

Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue · last filed 2013-03-29

2012-12-29: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $15.54K.
2012-09-29: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $81.60K.
2012-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $53.20K.

Period end	Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value
2012-12-29	$15.54K 10-K · filed 2013-03-29
2012-09-29	$81.60K 10-Q · filed 2012-11-08
2012-06-30	$53.20K 10-Q/A · filed 2012-08-10

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
USANA HEALTH SCIENCES INC (USNA)	United States	$0.264B	-17.90
FITLIFE BRANDS, INC. (FTLF)	United States	$0.087B	16.59
Canopy Growth Corp (CGC)		$0.395B
MANNATECH INC (MTEX)	United States	$0.014B
NATURAL ALTERNATIVES INTERNATIONAL INC (NAII)	United States	$0.011B	-1.16
Synergy CHC Corp. (SNYR)	United States	$0.001B
Functional Brands Inc. (MEHA)	United States	$0.001B
Tilray Brands, Inc. (TLRY)	United States	$0.554B	-5.97
Cronos Group Inc. (CRON)		$1.223B
Definium Therapeutics, Inc. (DFTX)	United States	$4.931B	-17.87